178 related articles for article (PubMed ID: 20112841)
1. FDC of montelukast with levocetirizine: focus on bilayer technology.
Rathod RT; Misra D
J Indian Med Assoc; 2009 Aug; 107(8):562-4. PubMed ID: 20112841
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
[TBL] [Abstract][Full Text] [Related]
3. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
[TBL] [Abstract][Full Text] [Related]
4. Long term treatment with montelukast and levocetirizine combination in persistent allergic rhinitis: review of recent evidence.
Adsule SM; Misra D
J Indian Med Assoc; 2010 Jun; 108(6):381-2. PubMed ID: 21121394
[TBL] [Abstract][Full Text] [Related]
5. Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine.
Ciebiada M; Barylski M; Gorska Ciebiada M
Am J Rhinol Allergy; 2013; 27(2):e58-62. PubMed ID: 23562192
[TBL] [Abstract][Full Text] [Related]
6. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacokinetics and tolerability of montelukast/levocetirizine administered as a fixed-dose combination and as separate tablets.
Kim S; Ko JW; Kim JR
Int J Clin Pharmacol Ther; 2018 Sep; 56(9):443-450. PubMed ID: 30021691
[TBL] [Abstract][Full Text] [Related]
8. Combined mediator antagonism for allergic rhinitis.
Jackson CM; Lipworth BJ
Allergy; 2004 Mar; 59(3):276-9. PubMed ID: 14982508
[No Abstract] [Full Text] [Related]
9. Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar
Marrouche N; Williams HC
Indian J Dermatol Venereol Leprol; 2018; 84(1):59-60. PubMed ID: 29271368
[No Abstract] [Full Text] [Related]
10. Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.
Phan H; Moeller ML; Nahata MC
Drugs; 2009; 69(18):2541-76. PubMed ID: 19943707
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
Sarkar TK; Sil A; Pal S; Ghosh C; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910
[TBL] [Abstract][Full Text] [Related]
12. Effects of montelukast on quality of life in patients with persistent allergic rhinitis.
Cingi C; Ozlugedik S
Otolaryngol Head Neck Surg; 2010 May; 142(5):654-8. PubMed ID: 20416451
[TBL] [Abstract][Full Text] [Related]
13. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of aspirin-induced angioedema with an association of leukotriene inhibitors and antihistamines].
Eymard B; Cousin F; Nicolas JF
Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):787-8. PubMed ID: 14576611
[No Abstract] [Full Text] [Related]
15. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.
Bachert C; Bousquet J; Canonica GW; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Van Hammée G;
J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324
[TBL] [Abstract][Full Text] [Related]
16. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis.
Lee CF; Sun HL; Lu KH; Ku MS; Lue KH
Pediatr Allergy Immunol; 2009 Aug; 20(5):493-9. PubMed ID: 19175892
[TBL] [Abstract][Full Text] [Related]
17. Effect of combination of montelukast and levocetirizine on otitis media with effusion: a prospective, placebo-controlled trial.
Ertugay CK; Cingi C; Yaz A; San T; Ulusoy S; Erdogmus N; Ertugay OC
Acta Otolaryngol; 2013 Dec; 133(12):1266-72. PubMed ID: 23972320
[TBL] [Abstract][Full Text] [Related]
18. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
19. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters.
Pasquali M; Baiardini I; Rogkakou A; Riccio AM; Gamalero C; Descalzi D; Folli C; Passalacqua G; Canonica GW
Clin Exp Allergy; 2006 Sep; 36(9):1161-7. PubMed ID: 16961716
[TBL] [Abstract][Full Text] [Related]
20. A treatment for allergic rhinitis: a view on the role of levocetirizine.
Holgate S; Powell R; Jenkins M; Ali O
Curr Med Res Opin; 2005 Jul; 21(7):1099-106. PubMed ID: 16004679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
